A variety of diseases affect the viability and function of motor neurons located within the spinal cord and projecting to muscle throughout the body. In order to develop an effective gene therapy application to treat MN disease it will be necessary to efficiently transduce MNs in vivo. Herpes simplex virus type 1 (HSV-1) has been engineered to be a versatile gene vector for transduction of sensory nerves in vivo, the natural site for wild-type virus latency. While high multiplicity infection of spinal cord will result in virus transduction of motor neurons (MNs), replication defective HSV vectors fail to transduce motor neurons in adult rodent models following skin or muscle inoculation. A similar result is likely to occur in human gene therapy applications since HSV is not found in MNs in natural infections. Thus treatment of MN diseases will require the enhancement of HSV vector infection of MNs with the longer-range goal of limiting the virus host-range to MN receptors. Because little is known about the effects of introducing new receptor binding ligands into the HSV-1 envelope, the applicants will explore strategies to enhance and eventually retarget HSV infection to MNs through modification of the receptor binding activities of three fundamentally different envelope components, glycoproteins B, C, and D. Because tetanus toxin receptors (TTR) are specifically found on MN synaptic junctions, we will focus our efforts on using nontoxic TTR binding components of the tetanus toxin engineered to be presented on the virus envelope as recombinant glycoproteins capable of initiating virus attachment and entry into MNs both in vitro and in vivo.
Aim 1 is designed to target HSV to MNs by substitution of the native heparan sulfate attachment determinants presented by HSV glycoproteins B and C (gB and gC) with a tetanus toxin (TTx) heavy chain C-terminal fragment (HcC).
Aim 2 is intended to restrict virus infection via HveB binding and evaluate re-targeting of gD via HcC.
Aim 3 is designed to test soluble HveC in combination with HcC ligand bearing gC and gB or HveC-HcC soluble fusion proteins as effectors of MN targeting. The soluble HveC adapter will be expected to block gD binding to cellular HveC while directly or indirectly re-targeting the virus to TTx receptors.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS044323-04
Application #
6914416
Study Section
Special Emphasis Panel (ZRG1-BDCN-3 (01))
Program Officer
Nunn, Michael
Project Start
2002-07-03
Project End
2006-06-30
Budget Start
2005-07-01
Budget End
2006-06-30
Support Year
4
Fiscal Year
2005
Total Cost
$355,063
Indirect Cost
Name
University of Pittsburgh
Department
Genetics
Type
Schools of Medicine
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Goins, William F; Hall, Bonnie; Cohen, Justus B et al. (2016) Retargeting of herpes simplex virus (HSV) vectors. Curr Opin Virol 21:93-101
Frampton Jr, Arthur R; Uchida, Hiroaki; von Einem, Jens et al. (2010) Equine herpesvirus type 1 (EHV-1) utilizes microtubules, dynein, and ROCK1 to productively infect cells. Vet Microbiol 141:12-21
Uchida, Hiroaki; Shah, Waris A; Ozuer, Ali et al. (2009) Generation of herpesvirus entry mediator (HVEM)-restricted herpes simplex virus type 1 mutant viruses: resistance of HVEM-expressing cells and identification of mutations that rescue nectin-1 recognition. J Virol 83:2951-61
Srinivasan, Rahul; Wolfe, Darren; Goss, James et al. (2008) Protein kinase C epsilon contributes to basal and sensitizing responses of TRPV1 to capsaicin in rat dorsal root ganglion neurons. Eur J Neurosci 28:1241-54
Frampton Jr, Arthur R; Stolz, Donna B; Uchida, Hiroaki et al. (2007) Equine herpesvirus 1 enters cells by two different pathways, and infection requires the activation of the cellular kinase ROCK1. J Virol 81:10879-89
Srinivasan, Rahul; Huang, Shaohua; Chaudhry, Suchita et al. (2007) An HSV vector system for selection of ligand-gated ion channel modulators. Nat Methods 4:733-9
Hong, C-S; Goins, W F; Goss, J R et al. (2006) Herpes simplex virus RNAi and neprilysin gene transfer vectors reduce accumulation of Alzheimer's disease-related amyloid-beta peptide in vivo. Gene Ther 13:1068-79
Jiang, Canping; Ataai, Mohammad; Ozuer, Ali et al. (2006) Inactivation of herpes simplex type 1 gene vector on immobilized metal affinity chromatography: oxidative damage by hydroxyl free radicals and its prevention. Biotechnol Bioeng 95:48-57
Jiang, Canping; Glorioso, Joseph C; Ataai, Mohammad (2006) Presence of imidazole in loading buffer prevents formation of free radical in immobilized metal affinity chromatography and dramatically improves the recovery of herpes simplex virus type 1 gene therapy vectors. J Chromatogr A 1121:40-5
Frampton Jr, Arthur R; Goins, William F; Cohen, Justus B et al. (2005) Equine herpesvirus 1 utilizes a novel herpesvirus entry receptor. J Virol 79:3169-73

Showing the most recent 10 out of 13 publications